Renal Cell Carcinoma News

RENAL CELL CARCINOMA ADVISOR

Renal Cell Carcinoma News

Hand opening a white medicine bottle

Triplet Outperforms Doublet in RCC

Adding cabozantinib to first-line treatment with ipilimumab plus nivolumab improved progression-free survival in patients with advanced, intermediate- or poor-risk renal cell carcinoma.